Given the prevalence of somatic activating mutations in cutaneous melanomas [35], we first assessed BRAF mutational status in the initial eCTC populations from 11 patients: V600 activating mutations in BRAF were determined using primer-specific RT/PCR and size analysis. Here, BRAF is linked to cutaneous melanoma.